Literature DB >> 27861742

Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes.

Lily Ong1, Ian M Morison2, Elizabeth C Ledgerwood1.   

Abstract

Thrombocytopenia Cargeeg is a rare autosomal dominant disorder and one of three thrombocytopenias caused by mutation of cytochrome c (Online Mendelian Inheritance in Man entry THC4). Our previous observations of platelet-like structures in the marrow space and early platelet production in vitro suggested that the low platelet phenotype in Thrombocytopenia Cargeeg subjects is caused by premature release of platelets into non-vascular regions of the bone marrow. We now show that two processes of platelet release occur in Thrombocytopenia Cargeeg subjects. Circulating platelets have a normal marginal microtubule coil, and cultured megakaryocytes derived from peripheral blood cells of Thrombocytopenia Cargeeg subjects form proplatelets normally and release platelets containing a marginal microtubule coil, consistent with effective platelet release via the proplatelet mechanism. In contrast, platelet-like structures within the extravascular bone marrow space have the dimensions of platelets but lack the marginal microtubule coil, suggesting abnormal proplatelet-independent platelet release. The mechanism of extravascular platelet release remains unclear. The failure to recapitulate this mechanism in vitro implies that the phenotype is not simply an intrinsic property of CYCS mutation-carrying megakaryocytes, but is dependent on the interaction between these cells and their environment.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  CYCS-related thrombocytopenia; cytochrome c; human bone marrow; megakaryopoiesis; thrombopoiesis

Mesh:

Substances:

Year:  2016        PMID: 27861742     DOI: 10.1111/bjh.14421

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Mitochondrial dynamics and reactive oxygen species initiate thrombopoiesis from mature megakaryocytes.

Authors:  Sonia Poirault-Chassac; Valérie Nivet-Antoine; Amandine Houvert; Alexandre Kauskot; Evelyne Lauret; René Lai-Kuen; Isabelle Dusanter-Fourt; Dominique Baruch
Journal:  Blood Adv       Date:  2021-03-23

2.  Naturally Occurring A51V Variant of Human Cytochrome c Destabilizes the Native State and Enhances Peroxidase Activity.

Authors:  Haotian Lei; Bruce E Bowler
Journal:  J Phys Chem B       Date:  2019-10-14       Impact factor: 2.991

Review 3.  Hereditary thrombocytopenias: a growing list of disorders.

Authors:  Patrizia Noris; Alessandro Pecci
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Effect of a K72A Mutation on the Structure, Stability, Dynamics, and Peroxidase Activity of Human Cytochrome c.

Authors:  Shiloh M Nold; Haotian Lei; Tung-Chung Mou; Bruce E Bowler
Journal:  Biochemistry       Date:  2017-06-21       Impact factor: 3.162

5.  The importance of Asn52 in the structure-function relationship of human cytochrome c.

Authors:  Dan Lou; Xi-Chun Liu; Xiao-Juan Wang; Shu-Qin Gao; Ge-Bo Wen; Ying-Wu Lin
Journal:  RSC Adv       Date:  2020-12-18       Impact factor: 4.036

6.  Differentiation and cell density upregulate cytochrome c levels in megakaryoblastic cell lines: Implications for analysis of CYCS-associated thrombocytopenia.

Authors:  Lily Ong; Kirstin O McDonald; Elizabeth C Ledgerwood
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

7.  Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy.

Authors:  Hongyan Yao; Danli Xin; Zongyi Zhan; Zijing Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-05       Impact factor: 2.629

8.  Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes.

Authors:  Bin Chen; Yuanbo Luo; Xueran Kang; Yuxing Sun; Chenyan Jiang; Bin Yi; Xiaojun Yan; Yisheng Chen; Runjie Shi
Journal:  Front Genet       Date:  2022-09-29       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.